AAAAAA

   
Results: 1-10 |
Results: 10
A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lungcancer cells
Authors: Nokihara, H Yano, S Nishioka, Y Hanibuchi, M Higasida, T Tsuruo, T Sone, S
Citation: H. Nokihara et al., A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lungcancer cells, JPN J CANC, 92(7), 2001, pp. 785-792
Transduction of KAI1/CD82 cDNA promotes hematogenous spread of human lung-cancer cells in natural killer cell-depleted SCID mice
Authors: Shinohara, T Nishimura, N Hanibuchi, MA Nokihara, H Miki, T Hamada, H Sone, S
Citation: T. Shinohara et al., Transduction of KAI1/CD82 cDNA promotes hematogenous spread of human lung-cancer cells in natural killer cell-depleted SCID mice, INT J CANC, 94(1), 2001, pp. 16-23
Nuclear factor-kappa B-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53
Authors: Shinohara, T Miki, T Nishimura, N Nokihara, H Hamada, H Mukaida, N Sone, S
Citation: T. Shinohara et al., Nuclear factor-kappa B-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53, CANCER RES, 61(2), 2001, pp. 673-678
Intrapleural therapy with MDP-Lys (L18), a synthetic derivative of muramyldipeptide, against malignant pleurisy associated with lung cancer
Authors: Yanagawa, H Haku, T Takeuchi, E Suzuki, Y Nokihara, H Sone, S
Citation: H. Yanagawa et al., Intrapleural therapy with MDP-Lys (L18), a synthetic derivative of muramyldipeptide, against malignant pleurisy associated with lung cancer, LUNG CANC, 27(2), 2000, pp. 67-73
Natural killer cell-dependent suppression of systemic spread of human lungadenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice
Authors: Nokihara, H Yanagawa, H Nishioka, Y Yano, S Mukaida, N Matsushima, K Sone, S
Citation: H. Nokihara et al., Natural killer cell-dependent suppression of systemic spread of human lungadenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice, CANCER RES, 60(24), 2000, pp. 7002-7007
Therapeutic efficacy of a new topoisomerase I and II inhibitor TAS-103, against both P-glycoprotein-expressing and -nonexpressing drug-resistant human small-cell lung cancer
Authors: Parajuli, P Yano, S Nishioka, Y Nokihara, H Hanibuchi, M Nishimura, N Utsugi, T Sone, S
Citation: P. Parajuli et al., Therapeutic efficacy of a new topoisomerase I and II inhibitor TAS-103, against both P-glycoprotein-expressing and -nonexpressing drug-resistant human small-cell lung cancer, ONCOL RES, 11(5), 1999, pp. 219-224
Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing
Authors: Parajuli, P Nishioka, Y Nishimura, N Singh, SM Hanibuchi, M Nokihara, H Yanagawa, H Sone, S
Citation: P. Parajuli et al., Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing, J LEUK BIOL, 65(6), 1999, pp. 764-770
Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice
Authors: Sone, S Yano, S Hanibuchi, M Nokihara, H Nishimura, N Miki, T Nishioka, Y Shinohara, T
Citation: S. Sone et al., Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice, CANC CHEMOT, 43, 1999, pp. S26-S31
Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted scid
Authors: Yano, S Hanibuchi, M Nishioka, Y Nokihara, H Nishimura, N Tsuruo, T Sone, S
Citation: S. Yano et al., Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted scid, INT J CANC, 82(1), 1999, pp. 105-111
Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice
Authors: Nokihara, H Nishioka, Y Yano, S Mukaida, N Matsushima, K Tsuruo, T Sone, S
Citation: H. Nokihara et al., Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice, INT J CANC, 80(5), 1999, pp. 773-780
Risultati: 1-10 |